Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
12/2008
12/17/2008EP2001863A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
12/17/2008EP2001844A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/17/2008EP1443822B1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones
12/17/2008CN101325958A Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate
12/17/2008CN101325954A Quinazolinone derivatives as vanilloid antagonists
12/17/2008CN101323622A 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
12/17/2008CN100443555C Fibre-reactive azo dyes, their preparation and their use
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465747 Fluorescent label compounds
12/16/2008US7465743 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors
12/16/2008US7465741 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative
12/16/2008US7465732 (2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives
12/16/2008US7465727 e.g. 4-[2-(4-Diethylaminomethyl-phenyl)-1,9b-dihydro-5-oxa-3,3a-diaza-cyclopenta[a]-naphthalene-4-carbonyl]-benzonitrile; AIDS and HIV multidrug resistantce; inhibitors of the viral replication of the HIV virus opposed to inhibitors of reverse transcriptase (RT) or protease
12/11/2008WO2008148449A1 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors
12/11/2008WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety
12/11/2008WO2008082009A3 Fused substituted aminopyrrolidine derivative
12/11/2008WO2008001182A8 Tricyclic heteroaryl compounds as pde10 inhibitors
12/11/2008US20080306278 Process
12/11/2008US20080306059 Pyrimido [4,5-B] -Oxazines For Use as Dgat Inhibitors
12/11/2008CA2689554A1 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours
12/10/2008EP2000472A1 Rapamycin Analogs Containing an Antioxidant Moiety
12/10/2008EP2000471A1 Rapamycin Analogs Containing an Antioxidant Moiety
12/10/2008EP2000470A1 Rapamycin Analogs Containing an Antioxidant Moiety
12/10/2008CN101321770A Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
12/10/2008CN101321769A Process for the preparation of purified crystalline CCI-779
12/10/2008CN101321768A 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
12/10/2008CN101321765A Chromone derivatives useful as antagonists of VR1 receptors
12/10/2008CN101318968A Benzoxazine-pyrazoles and opened loop compound
12/09/2008US7462717 e.g. 3-{4-[3-(4-fluoro-phenyl)-2-methyl-allyl]-piperazin-1-ylmethyl}-7,8-dimethoxy-3a,4-dihydro-3H-chromeno [4,3-c]isoxazol-6-yl)-pyridin-4-yl-amine; serotonin (5-HT) reuptake inhibitor and alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; psycosis, Parkinson's disease
12/09/2008US7462713 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
12/09/2008US7462633 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/04/2008WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
12/04/2008WO2008144931A1 Compositions and methods for modulating gated ion channels
12/04/2008WO2008108378A3 Bicyclic oxomorpholine derivative
12/04/2008WO2008035315A3 Inhibitors of phosphodiesterase type-iv
12/04/2008WO2007098229A3 Geldanamycin derivatives and method of use thereof
12/04/2008US20080300243 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/04/2008US20080300241 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
12/04/2008CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
12/03/2008EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors
12/03/2008EP1997810A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997809A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
12/03/2008EP1831230B1 Process for obtaining levofloxacin free from salts
12/03/2008EP1250337B1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
12/03/2008CN101316852A Inhibitors of serine proteases
12/03/2008CN101316846A Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia
12/02/2008US7459463 Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
12/02/2008US7459451 Pyrazolopyridine derivatives
12/02/2008US7459449 Olanzapine malonate, olanzapine glycolate, and olanzapine benzoate; antipsychotic agents; water soluble; can form tablets by direct compression; may be mixed with dibasic calcium phosphate and/or hydroxypropyl cellulose
12/02/2008CA2257803C Non immunosuppressive antifungal rapalogs
12/02/2008CA2131087C Streptomyces strains and methods for selectively producing a single streptogramin component
11/2008
11/27/2008WO2008144567A1 Method of purification of rapamycin and its analogs by use of cascade chromatography
11/27/2008WO2008144507A2 Spirooxindole inhibitors of aurora kinase
11/27/2008WO2008144399A1 COMPLEXES COMPRISING α2-ADRENERGIC RECEPTOR AGONISTS AND COMPOSITIONS
11/27/2008WO2008143343A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
11/27/2008WO2008141455A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/27/2008WO2007143468A3 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
11/27/2008WO2007106852A3 Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293708 Pyrimidine Derivatives
11/27/2008US20080293690 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/27/2008US20080293650 Fused Heterocyclic Compounds and Use Thereof
11/27/2008US20080290329 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
11/27/2008CA2688776A1 Oxo bridged diazepan orexin receptor antagonists
11/27/2008CA2688008A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
11/27/2008CA2687338A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/27/2008CA2686016A1 Quinoline derivatives as pi3 kinase inhibitors
11/26/2008EP1994020A2 Substituted quinolones iii
11/26/2008EP1993994A2 Deuterated hepatitis c protease inhibitors
11/26/2008CN101312976A Spirocyclic compounds as hdac inhibitors
11/26/2008CN101312965A Morpholine type cinnamide compound
11/26/2008CN101311176A Isoquinoline compounds, preparation method and use thereof
11/26/2008CN100436454C Novel harringtonlne derivative, method for making same and its pharmaceutical composition and use thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436425C Fused imidazolium derivatives
11/25/2008US7456177 Heteroaryl fused azapolycyclic compounds which bind to neuronal nicotinic acetylcholine specific receptor sites, and which are useful in modulating cholinergic function, for for reducing nicotine addiction or aiding in the cessation or lessening of tobacco use in a mammal, therapy
11/25/2008US7456163 Macrocycles useful in the treatment of alzheimer's disease
11/25/2008US7455853 Medical devices containing rapamycin analogs
11/20/2008WO2008140421A2 Heterocycloalkyl substituted pyrimidine derivatives
11/20/2008WO2008140420A2 Pyrimidine derivatives
11/20/2008WO2008140419A2 Pyridyl substituted pyrimidine derivatives
11/20/2008WO2008140090A1 Epoxy compound and method for manufacturing the same
11/20/2008WO2008030412A3 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
11/20/2008US20080287675 Cascade system
11/20/2008US20080287483 Polyketides and Their Synthesis and Use
11/20/2008US20080287482 Production of Polyketides and Other Natural Products
11/20/2008US20080287473 Novel molecules for regulating cell death
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287428 Novel Heterocyclidene Acetamide Derivative
11/20/2008US20080287414 Mitotic Kinesin Inhibitors
11/20/2008US20080286842 for the production of macrolides such as Tacrolimus, sirolimus
11/20/2008US20080286820 Novel phenoxazinone derivatives as enzyme substrates and use thereof as indicator in the detection of microorganisms with peptidase activity
11/20/2008CA2686092A1 Epoxy compound and method for manufacturing the same
11/19/2008EP1992629A1 Preparation of levofloxacin and forms thereof
11/19/2008EP1992628A1 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
11/19/2008EP1991551A1 Meridamycin analogues for the treatment of neurodegenerative disorders
11/19/2008EP1991549A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
11/19/2008EP1991223A1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 220